ArticleWorld journal of surgical oncology2022

Real-world data on breast pathologic complete response and disease-free survival after neoadjuvant chemotherapy for hormone receptor-positive, human epidermal growth factor receptor-2-negative breast cancer: a multicenter, retrospective study in China.

Dandan Guan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.